Diagnos Inc.
ADK.V
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -31.18% | 12.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -31.18% | 12.05% | |||
| Cost of Revenue | 0.14% | -6.16% | |||
| Gross Profit | -3.11% | 7.58% | |||
| SG&A Expenses | 23.75% | 31.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.26% | 18.20% | |||
| Operating Income | -18.44% | -18.36% | |||
| Income Before Tax | -7.51% | -15.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.51% | -15.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.51% | -15.96% | |||
| EBIT | -18.44% | -18.36% | |||
| EBITDA | -21.79% | -19.07% | |||
| EPS Basic | -2.17% | -1.10% | |||
| Normalized Basic EPS | -1.72% | -1.75% | |||
| EPS Diluted | -2.17% | -1.10% | |||
| Normalized Diluted EPS | -1.72% | -1.75% | |||
| Average Basic Shares Outstanding | 5.60% | 13.81% | |||
| Average Diluted Shares Outstanding | 5.60% | 13.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||